Patents by Inventor Susan Arnold

Susan Arnold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
    Publication number: 20220288170
    Abstract: The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Application
    Filed: January 25, 2022
    Publication date: September 15, 2022
    Inventors: Lynne GEORGOPOULOS, Susan ARNOLD, David James BALLANCE
  • Methods and compositions for treating muscle disease and disorders
    Patent number: 11266719
    Abstract: The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more clastin-like peptides and can be administered at a low-dose.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: March 8, 2022
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne Georgopoulos, Susan Arnold, David James Ballance
  • METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
    Publication number: 20220023390
    Abstract: The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Application
    Filed: July 1, 2021
    Publication date: January 27, 2022
    Inventors: Susan ARNOLD, David James BALLANCE
  • Methods and compositions for treating cystic fibrosis
    Patent number: 11052132
    Abstract: The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: July 6, 2021
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Susan Arnold, David James Ballance
  • METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
    Publication number: 20210069299
    Abstract: The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more clastin-like peptides and can be administered at a low-dose.
    Type: Application
    Filed: June 22, 2020
    Publication date: March 11, 2021
    Inventors: Lynne GEORGOPOULOS, Susan ARNOLD, David James BALLANCE
  • Use of modified vasoactive intestinal peptides in the treatment of hypertension
    Patent number: 10940182
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Grant
    Filed: September 26, 2016
    Date of Patent: March 9, 2021
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • Methods and compositions for treating muscle disease and disorders
    Patent number: 10688156
    Abstract: The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Grant
    Filed: February 9, 2016
    Date of Patent: June 23, 2020
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne Georgopoulos, Susan Arnold, David James Ballance
  • METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS
    Publication number: 20180333467
    Abstract: The present disclosure provides a method of treating muscle myopathy, including muscle dystrophies and cardiomyopathies, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Application
    Filed: February 9, 2016
    Publication date: November 22, 2018
    Inventors: Lynne GEORGOPOULOS, Susan ARNOLD, David James BALLANCE
  • Method for administering a sustained release formulation
    Patent number: 9919032
    Abstract: The present invention provides pharmaceutical formulations for sustained release when administered at cold temperatures, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs.
    Type: Grant
    Filed: November 18, 2016
    Date of Patent: March 20, 2018
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Susan Arnold, Christopher Prior, Lynne Georgopoulos
  • METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
    Publication number: 20170182130
    Abstract: The present disclosure provides a method of treating diseases or disorders associated with CFTR protein dysfunction, including Cystic Fibrosis, by administering stable, long-lasting vasoactive intestinal peptide therapeutic agents. These agents include one or more elastin-like peptides and can be administered at a low-dose.
    Type: Application
    Filed: May 8, 2015
    Publication date: June 29, 2017
    Inventors: Susan ARNOLD, David James BALLANCE
  • FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
    Publication number: 20170136092
    Abstract: The present invention provides pharmaceutical formulations for sustained release when administered at cold temperatures, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs.
    Type: Application
    Filed: November 18, 2016
    Publication date: May 18, 2017
    Inventors: Susan ARNOLD, Christopher PRIOR, Lynne GEORGOPOULOS
  • USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION
    Publication number: 20170072021
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Application
    Filed: September 26, 2016
    Publication date: March 16, 2017
    Inventors: Lynne M. GEORGOPOULOS, Susan ARNOLD
  • Use of modified vasoactive intestinal peptides in the treatment of hypertension
    Patent number: 9561262
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Grant
    Filed: June 6, 2012
    Date of Patent: February 7, 2017
    Assignee: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • THERAPEUTIC AGENTS, COMPOSITIONS, AND METHODS FOR GLYCEMIC CONTROL
    Publication number: 20150361154
    Abstract: The present invention relates in part to insulin proteins and pharmaceutical compositions having therapeutic advantages.
    Type: Application
    Filed: January 15, 2014
    Publication date: December 17, 2015
    Inventors: James JOWETT, Christopher WOODS, Susan ARNOLD
  • FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
    Publication number: 20150290328
    Abstract: The present invention provides pharmaceutical formulations for sustained release when administered at cold temperatures, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs.
    Type: Application
    Filed: November 20, 2013
    Publication date: October 15, 2015
    Inventors: Susan Arnold, Christopher Prior, Lynne Georgopoulos
  • USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION
    Publication number: 20150111829
    Abstract: The present invention is based on the discovery that a VIP having a binding preference for VPAC2 can provide long-acting blood pressure control synergistically with concomitant anti-hypertensive therapies. Accordingly, methods and compositions useful for the treatment and/or amelioration of hypertension are provided.
    Type: Application
    Filed: June 6, 2012
    Publication date: April 23, 2015
    Applicant: PHASEBIO PHARMACEUTICALS, INC.
    Inventors: Lynne M. Georgopoulos, Susan Arnold
  • FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE
    Publication number: 20140171370
    Abstract: The present invention provides pharmaceutical formulations for sustained release, and methods for delivering a treatment regimen with a combination of sustained release and long half-life formulations. The invention provides improved pharmacokinetics for peptide and small molecule drugs.
    Type: Application
    Filed: December 6, 2013
    Publication date: June 19, 2014
    Applicant: PhaseBio Pharmaceuticals, Inc.
    Inventors: Susan Arnold, Christopher Prior
  • Over the counter medicine container with surface ornamentation
    Patent number: D824251
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: July 31, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Andreina Eugenia Marcano Torres, Susan Arnold, Amy Marie Kletz, Andrew Bernard Tesnar
  • Over the counter medicine container with surface ornamentation
    Patent number: D826710
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: August 28, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Andreina Eugenia Marcano Torres, Susan Arnold, Amy Marie Kletz, Andrew Bernard Tesnar
  • Over the counter medicine container with surface ornamentation
    Patent number: D827428
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: September 4, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Andreina Eugenia Marcano Torres, Susan Arnold, Amy Marie Kletz, Andrew Bernard Tesnar